Short Description:
CAS number: 23541-50-6
Molecular formula: C27H30ClNO10
Molecular weight:563.98
Chemical structure:
| Basic Information | |
| Product name | Daunorubicin hydrochloride |
| CAS No. | 23541-50-6 |
| Color | Red to deep red |
| Form | Solid |
| Stability: | Stability |
| Solubility | Freely soluble in water and in methanol, slightly soluble in alcohol, practically insoluble in acetone. |
| Water Solubility | Soluble in water (50 mM) |
| Storage | Inert atmosphere,2-8°C |
| Shelf Life | 2 Years |
| Package | 25kg/Drum |
Product Description
Daunorubicin hydrochloride (23541-50-6) is an antitumor antibiotic used in the treatment of acute myeloid leukemias.1?Induces DNA damage by intercalation.2?Induces apoptosis in a variety of cell lines.3?Inhibition of autophagy with chloroquine enhances daunorubicin-induced apoptosis in K562 cells.4?Cell permeable
Application
Daunorubicin hydrochloride is a chemotherapy medication used to treat certain types of leukemia and other cancers. It belongs to the class of drugs known as anthracyclines and works by interfering with the growth and spread of cancer cells in the body.
Daunorubicin hydrochloride is typically administered intravenously by a healthcare professional in a clinical setting. The dosage and frequency of treatment will depend on the specific type of cancer being treated, as well as the patient's overall health and individual response to the medication.
It is important to carefully follow the healthcare provider's instructions for receiving daunorubicin hydrochloride and to attend all scheduled appointments for monitoring and evaluation during treatment. This medication can have serious side effects, and patients should communicate any concerns or changes in their condition to their healthcare team.
Common side effects of daunorubicin hydrochloride may include nausea, vomiting, hair loss, and increased susceptibility to infections. Serious side effects such as heart problems and bone marrow suppression can also occur and require immediate medical attention.
As with all chemotherapy medications, daunorubicin hydrochloride should only be used under the supervision of a qualified healthcare professional experienced in the use of cancer treatment drugs. It is important to discuss any existing medical conditions or medications with the healthcare provider before starting treatment with daunorubicin hydrochloride.
